Loading provider…
Loading provider…
Hematology & Oncology Physician in Milwaukee, WI
NPI: 1295930519Primary Practice Location
FROEDTERT MEMORIAL LUTHERAN HOSPITAL
900 N 92nd St, Milwaukee, WI
Primary Employer
The Medical College of Wisconsin, Inc.
mcw.edu
HQ Phone
Get M.D. Ben's Phone Numberphone_androidMobile
Get M.D. Ben's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWI State Medical License
WI State Medical License
2007 - 2025

American Board of Internal Medicine
Medical Oncology
Medical College Of Wisconsin
mcw.edu
Fellowship • Hematology and Medical Oncology
2007 - 2010
Gundersen Lutheran Medical Foundation
Residency • Internal Medicine
2005 - 2007
University of Toledo
Internship • Internal Medicine
2004 - 2005
University of Kerala Medical College
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 52 | 97 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 50 | 204 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 22 | 22 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 14 | 16 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 14 | 47 |
Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma.
Authors: Bluemke, Emma, Bulte, Daniel, Bertrand, Ambre, George, Ben, Cooke, Rosie, Chu, Kwun-Ye, Durrant, Lisa, Goh, Vicky, Jacobs, Clare, Ng, Stasya M, Strauss, Victoria Y, Hawkins, Maria A, Muirhead, Rebecca
Journal: Clin Transl Radiat Oncol
Publication Date: 2020-03-18
Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?
Authors: Douglas Evans, Tracy Kelly, James Thomas, Kathleen Christians, Paul Ritch
Publication Date: 2014-02-27
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, DRUG: Capecitabine, DRUG: Etoposide
Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Nivolumab, DRUG: Cyclophosphamide, RADIATION: Stereotactic Body Radiation (SBRT), DRUG: GVAX Pancreas Vaccine
Lead Sponsor: Medical College of Wisconsin
Intervention / Treatment: DRUG: Targeted agent, DRUG: Standard of care agent